Author(s): No authors listed, No authors listed
Abstract Share this page
Abstract We have reported that angiogenic primary breast carcinoma can relapse not only as angiogenic, but also as non-angiogenic, lung metastases. This non-angiogenic pathway seems to be a novel pathway of cancer progression, and such tumours are likely to be resistant to antiangogenic treatment.
This article was published in Lancet
and referenced in Journal of Lung Cancer Diagnosis & Treatment